MDMX regulation of p53 response to ribosomal stress
Open accessAbstract
Ribosomal stress such as disruption of rRNA biogenesis activates p53 by release of ribosomal proteins from the nucleoli, which bind to MDM2 and inhibit p53 degradation. We found that p53 activation by ribosomal stress requires degradation of MDMX in an MDM2-dependent fashion. Tumor cells overexpressing MDMX are less sensitive to actinomycin D-induced growth arrest due to formation of inactive p53-MDMX complexes. Knockdown of MDMX increases sensitivity to actinomycin D, whereas MDMX overexpression abrogates p53 activation and prevents growth arrest. Furthermore, MDMX expression promotes resistance to the chemotherapeutic agent 5-fluorouracil (5-FU), which at low concentrations activates p53 by inducing ribosomal stress without significant DNA damage signaling. Knockdown of MDMX abrogates HCT116 tumor xenograft formation in nude mice. MDMX overexpression does not accelerate tumor growth but increases resistance to 5-FU treatment in vivo. Therefore, MDMX is an important regulator of p53 response to ribosomal stress and RNA-targeting chemotherapy agents.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Mdm2 and Mdmx bind many other proteins, including proteins involved in development, morphogenesis, and tumorigenesis.
“However, both Mdm2 and Mdmx interact with many other proteins, including those involved in development, morphogenesis and tumorigenesis (Table 2; [81–92]).”
From The p53 orchestra: Mdm2 and Mdmx set the tone (2010) · cites this paper as [88]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
5-Fluorouracil: mechanisms of action and clinical strategies
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332 · see citing works
Disruption of p53 in human cancer cells alters the responses to therapeutic agents.
Bunz, F., Hwang, P. M., Torrance, C., Waldman, T., Zhang, Y., Dillehay, L., Williams, J., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6863 · Cited by 1,044 · see citing works
The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia
Draptchinskaia, N., Gustavsson, P., Andersson, B., Pettersson, M., Willig, T.-N., Dianzani, I., Ball, S., Tchernia, G., Klar, J., Matsson, H., et al. (1999) · Nature Genetics · doi:10.1038/5951 · Cited by 795 · see citing works
ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage
Maya, R., Balass, M., Kim, S.-T., Shkedy, D., Leal, J.-F. M., Shifman, O., Moas, M., Buschmann, T., Ronai, Z., Shiloh, Y., et al. (2001) · Genes & Development · doi:10.1101/gad.886901 · Cited by 716 · see citing works
Mapping of the p53 and mdm-2 Interaction Domains
Chen, J., Maréchal, V., & Levine, A. J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.4107 · Cited by 689 · see citing works
Self-citationMDMX: a novel p53‐binding protein with some functional properties of MDM2.
Shvarts, A., Steegenga, W. T., Riteco, N., van Laar, T., Dekker, P., Bazuine, M., van Ham, R. C., van der Houven van Oordt, W., Hateboer, G., van der Eb, A. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00919.x · Cited by 648 · see citing works
Regulation of HDM2 activity by the ribosomal protein L11
Lohrum, M. A. E., Ludwig, R. L., Kubbutat, M. H. G., Hanlon, M., & Vousden, K. H. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00134-x · Cited by 626 · see citing works
Zhang, Y., Wolf, G. W., Bhat, K., Jin, A., Allio, T., Burkhart, W., & Xiong, Y. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.23.8902-8912.2003 · Cited by 556 · see citing works
p53 Mutation and MDM2 amplification in human soft tissue sarcomas.
Leach, F. S., Tokino, T., Meltzer, P. S., Burrell, M., Oliner, J., Smith, S., HILL, D. E., Sidransky, D., Kinzler, K. W., & Vogelstein, B. (1993) · PubMed · Cited by 533 · see citing works
Parant, J., Chavez-Reyes, A., Little, N. A., Yan, W., Reinke, V., Jochemsen, A. G., & Lozano, G. (2001) · Nature Genetics · doi:10.1038/ng714 · Cited by 517 · see citing works
Dai, M., Zeng, S. X., Jin, Y., Sun, X., David, L. L., & Lu, H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.17.7654-7668.2004 · Cited by 495 · see citing works
DNA damage-induced activation of ATM and ATM-dependent signaling pathways
Kurz, E. U., & Lees‐Miller, S. P. (2004) · DNA repair · doi:10.1016/j.dnarep.2004.03.029 · Cited by 478 · see citing works
Metabolism and mechanism of action of 5-fluorouracil
Parker, W. B., & Cheng, Y. C. (1990) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(90)90056-8 · Cited by 450 · see citing works
Many Ribosomal Protein Genes Are Cancer Genes in Zebrafish
Amsterdam, A., Sadler, K. C., Lai, K., Farrington, S. M., Bronson, R. T., Lees, J. A., & Hopkins, N. H. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020139 · Cited by 417 · see citing works
Accelerated MDM2 auto‐degradation induced by DNA‐damage kinases is required for p53 activation
Stommel, J. M., & Wahl, G. M. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600145 · Cited by 386 · see citing works
HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53
Linares, L. K., Hengstermann, A., Ciechanover, A., Müller, S., & Scheffner, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2030930100 · Cited by 361 · see citing works
Inhibition of HDM2 and Activation of p53 by Ribosomal Protein L23
Jin, A., Itahana, K., O’Keefe, K. J., & Zhang, Y. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.17.7669-7680.2004 · Cited by 356 · see citing works
Pestov, D. G., Strezoska, Ž., & Lau, L. F. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.13.4246-4255.2001 · Cited by 343 · see citing works
MDM2 interacts with MDMX through their RING finger domains
Tanimura, S., Ohtsuka, S., Mitsui, K., Shirouzu, K., Yoshimura, A., & Ohtsubo, M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00254-9 · Cited by 324 · see citing works
The Ribosomal L5 Protein Is Associated with mdm-2 and mdm-2-p53 Complexes
Maréchal, V., Elenbaas, B., Piette, J., Nicolas, J. C., & Levine, A. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.11.7414 · Cited by 318 · see citing works
Danovi, D., Meulmeester, E., Pasini, D., Migliorini, D., Capra, M., Frenk, R., de Graaf, P., Francoz, S., Gasparini, P., Gobbi, A., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.5835-5843.2004 · Cited by 310 · see citing works
Stabilization of the MDM2 Oncoprotein by Interaction with the Structurally Related MDMX Protein
Sharp, D. A., Kratowicz, S. A., Sank, M. J., & George, D. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.38189 · Cited by 286 · see citing works
Small-Molecule Antagonists of p53-MDM2 Binding: Research Tools and Potential Therapeutics
Vassilev, L. T. (2004) · Cell Cycle · doi:10.4161/cc.3.4.801 · Cited by 271 · see citing works
Mutual Dependence of MDM2 and MDMX in Their Functional Inactivation of p53
Gu, J., Kawai, H., Nie, L., Kitao, H., Wiederschain, D., Jochemsen, A. G., Parant, J. M., Lozano, G., & Yuan, Z.-M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200150200 · Cited by 265 · see citing works
Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells <i>in vivo</i>
Francoz, S., Froment, P., Bogaerts, S., De Clercq, S., Maetens, M., Doumont, G., Bellefroid, E., & Marine, J.-C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508476103 · Cited by 260 · see citing works
ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage
Chen, L., Gilkes, D. M., Pan, Y., Lane, W. S., & Chen, J. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600812 · Cited by 260 · see citing works
Self-citationEssential role of ribosomal protein L11 in mediating growth inhibition‐induced p53 activation
Bhat, K., Itahana, K., Jin, A., & Zhang, Y. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600247 · Cited by 249 · see citing works
Mapping of the p53 and mdm-2 Interaction Domains
Chen, J., Maréchal, V., & Levine, A. J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.4107-4114.1993 · Cited by 247 · see citing works
Self-citationMDM2 promotes ubiquitination and degradation of MDMX
Pan, Y., & Chen, J. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.15.5113-5121.2003 · Cited by 246 · cited 3× · see citing works
“MDMX can be ubiquitinated and degraded by MDM2 (de Graaf et al, 2003; Kawai et al, 2003; Pan and Chen, 2003), this may be an important mechanism for controlling MDMX level.”
BackgroundSelf-citationMdmx stabilizes p53 and Mdm2 via two distinct mechanisms
Stad, R., Little, N. A., Xirodimas, D. P., Frenk, R., van der Eb, A. J., Lane, D. P., Saville, M. K., & Jochemsen, A. G. (2001) · The EMBO Reports · doi:10.1093/embo-reports/kve227 · Cited by 234 · see citing works
Landers, J. E., Cassel, S., & George, D. L. (1997) · PubMed · Cited by 210 · see citing works
Tyrosine phosphorylation of Mdm2 by c‐Abl: implications for p53 regulation
Goldberg, Z., Sionov, R. V., Berger, M., Zwang, Y., Perets, R., Etten, R. A. V., Oren, M., Taya, Y., & Haupt, Y. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf384 · Cited by 200 · see citing works
Toledo, F., Krummel, K. A., Lee, C. J., Liu, C.-W., Rodewald, L.-W., Tang, M., & Wahl, G. M. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.014 · Cited by 199 · cited 1× · see citing works
“In contrast, MDMX is a stable protein that regulates p53 mainly by sequestering p53 into complexes (Francoz et al, 2006; Toledo et al, 2006).”
BackgroundPritchard, D. M., Watson, A. J. M., Potten, C. S., Jackman, A. L., & Hickman, J. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1795 · Cited by 198 · see citing works
mdmx is a negative regulator of p53 activity in vivo.
Finch, R. A., Donoviel, D. B., Potter, D., Shi, M., Fan, A., Freed, D. D., Wang, C.-Y., Zambrowicz, B., Ramírez‐Solis, R., Sands, A., et al. (2002) · PubMed · Cited by 192 · see citing works
Levels of HdmX expression dictate the sensitivity of normal and transformed cells to Nutlin-3
Patton, J. T., Mayo, L. D., Singhi, A. D., Gudkov, A. V., Stark, G. R., & Jackson, M. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3832 · Cited by 189 · see citing works
Mdmx as an essential regulator of p53 activity
Marine, J., & Jochemsen, A. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.151 · Cited by 186 · see citing works
Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage
Pereg, Y., Shkedy, D., de Graaf, P., Meulmeester, E., Edelson-Averbukh, M., Salek, M., Biton, S., Teunisse, A. F. A. S., Lehmann, W. D., Jochemsen, A. G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408595102 · Cited by 181 · see citing works
Control of p53 ubiquitination and nuclear export by MDM2 and ARF.
Zhang, Y., & Xiong, Y. (2001) · PubMed · Cited by 176 · see citing works
Mechanism of Repression of RNA Polymerase I Transcription by the Retinoblastoma Protein
Voit, R., Schäfer, K., & Grummt, I. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.8.4230 · Cited by 172 · see citing works
DNA damage-induced MDMX degradation is mediated by MDM2
Kawai, H., Wiederschain, D., Kitao, H., Stuart, J., Tsai, K. K. C., & Yuan, Z.-M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308295200 · Cited by 163 · see citing works
p53 represses ribosomal gene transcription
Budde, A., & Grummt, I. (1999) · Oncogene · doi:10.1038/sj.onc.1202402 · Cited by 157 · see citing works
Aberrant expression of HDMX proteins in tumor cells correlates with wild-type p53.
Ramos, Y. F., Stad, R. K., Attema, J., Peltenburg, L. T. C., van der Eb, A. J., & Jochemsen, A. G. (2001) · PubMed · Cited by 149 · see citing works
Hdmx protein stability is regulated by the ubiquitin ligase activity of Mdm2
de Graaf, P., Little, N. A., Ramos, Y. F. M., Meulmeester, E., Letteboer, S. J. F., & Jochemsen, A. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213034200 · Cited by 143 · see citing works
Houghton, J. A., Houghton, P. J., & Wooten, R. S. (1979) · PubMed · Cited by 142 · see citing works
Hannan, K. M., Hannan, R. D., Smith, S. D., Jefferson, L. S., Lun, M., & Rothblum, L. I. (2000) · Oncogene · doi:10.1038/sj.onc.1203875 · Cited by 131 · see citing works
Okamoto, K., Kashima, K., Pereg, Y., Ishida, M., Yamazaki, S., Nota, A., Teunisse, A., Migliorini, D., Kitabayashi, I., Marine, J.-C., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9608-9620.2005 · Cited by 129 · see citing works
Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3
LeBron, C., Chen, L., Gilkes, D. M., & Chen, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601032 · Cited by 122 · see citing works
Self-citation14‐3‐3γ binds to MDMX that is phosphorylated by UV‐activated Chk1, resulting in p53 activation
Jin, Y., Dai, M., Lu, S. Z., Xu, Y., Luo, Z., Zhao, Y., & Lu, H. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601010 · Cited by 113 · see citing works
The Ribosomal L5 Protein Is Associated with mdm-2 and mdm-2-p53 Complexes
Maréchal, V., Elenbaas, B., Piette, J. G., et al. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.11.7414-7420.1994 · Cited by 107 · see citing works
Ghoshal, K., & Jacob, S. T. (1994) · PubMed · Cited by 101 · see citing works
Longley, D. B., Boyer, J. D., Allen, W. L., Latif, T., Ferguson, P., Maxwell, P. J., McDermott, U., Lynch, M., Harkin, D. P., & Johnston, P. G. (2002) · PubMed · Cited by 100 · see citing works
Regulation of p53-MDMX interaction by casein kinase 1 alpha
Chen, L., Li, C., Pan, Y., & Chen, J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.15.6509-6520.2005 · Cited by 88 · see citing works
Self-citationMigliorini, D., Danovi, D., Colombo, E., Carbone, R., Pelicci, P. G., & Marine, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108795200 · Cited by 86 · see citing works
Hannan, K. M., Kennedy, B. K., Cavanaugh, A. H., Hannan, R. D., Hirschler‐Laszkiewicz, I., Jefferson, L. S., & Rothblum, L. I. (2000) · Oncogene · doi:10.1038/sj.onc.1203690 · Cited by 86 · see citing works
DNA Damage Induces MDMX Nuclear Translocation by p53-Dependent and -Independent Mechanisms
Li, C., Chen, L., & Chen, J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.21.7562-7571.2002 · Cited by 82 · see citing works
Self-citationmdm2 deletion does not alter growth characteristics of p53-deficient embryo fibroblasts.
McMasters, K. M., Luna, R. M. D. O., Peña, J., & Lozano, G. (1996) · PubMed · Cited by 47 · see citing works
Enhanced cytotoxicity with interleukin-1 alpha and 5-fluorouracil in HCT116 colon cancer cells.
Geoffroy, F., Allegra, C. J., Sinha, B. K., & Grem, J. L. (1994) · PubMed · Cited by 40 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Signaling to p53: ribosomal proteins find their way
Zhang, Y., & Lu, H. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.09.024 · Cited by 591 · see citing works
Coping with stress: multiple ways to activate p53
Horn, H. F., & Vousden, K. H. (2007) · Oncogene · doi:10.1038/sj.onc.1210263 · Cited by 522 · see citing works
The p53 orchestra: Mdm2 and Mdmx set the tone
Wade, M., Wang, Y. V., & Wahl, G. M. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.01.009 · Cited by 450 · see citing works
Nucleolus: the fascinating nuclear body
Sirri, V., Inchima, S. U., Roussel, P., & Hernandez‐Verdun, D. (2007) · Histochemistry and Cell Biology · doi:10.1007/s00418-007-0359-6 · Cited by 385 · see citing works
Nucleolar Stress: hallmarks, sensing mechanism and diseases
Yang, K., Yang, J., & Yi, J. (2018) · Cell Stress · doi:10.15698/cst2018.06.139 · Cited by 279 · see citing works
MDM2 and MDM4: p53 regulators as targets in anticancer therapy
Toledo, F., & Wahl, G. M. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.03.022 · Cited by 261 · see citing works
Mechanism of p53 stabilization by ATM after DNA damage
Cheng, Q., & Chen, J. (2010) · Cell Cycle · doi:10.4161/cc.9.3.10556 · Cited by 248 · see citing works
Self-citationMdm2 Regulates p53 mRNA Translation through Inhibitory Interactions with Ribosomal Protein L26
Ofir-Rosenfeld, Y., Boggs, K., Michael, D., Kastan, M. B., & Oren, M. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.08.031 · Cited by 240 · see citing works
Targeting tumour-supportive cellular machineries in anticancer drug development
Dobbelstein, M., & Moll, U. M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4201 · Cited by 229 · see citing works
Wang, W., Nag, S. A., Zhang, X., Wang, M., Wang, H., Zhou, J., & Zhang, R. (2014) · Medicinal Research Reviews · doi:10.1002/med.21327 · Cited by 223 · see citing works
Efficient p53 Activation and Apoptosis by Simultaneous Disruption of Binding to MDM2 and MDMX
Hu, B., Gilkes, D. M., & Chen, J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1140 · Cited by 214 · see citing works
Self-citationMacias, E., Jin, A., Deisenroth, C., Bhat, K., Mao, H., Lindström, M. S., & Zhang, Y. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.08.007 · Cited by 214 · see citing works
Ribosomal Protein S7 Is Both a Regulator and a Substrate of MDM2
Zhu, Y. Y., Poyurovsky, M. V., Li, Y., Biderman, L., Stahl, J., Jacq, X., & Prives, C. L. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.07.014 · Cited by 206 · see citing works
Ribosomal protein S14 unties the MDM2–p53 loop upon ribosomal stress
Zhou, X. Y., Hao, Q., Liao, J., Zhang, Q., & Lu, H. (2012) · Oncogene · doi:10.1038/onc.2012.63 · Cited by 176 · see citing works
The Regulation of Multiple p53 Stress Responses is Mediated through MDM2
Hu, W., Feng, Z., & Levine, A. J. (2012) · Genes & Cancer · doi:10.1177/1947601912454734 · Cited by 176 · see citing works
Phan, J., Li, Z., Kasprzak, A., Li, B., Sebti, S., Guida, W., Schönbrunn, E., & Chen, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.073056 · Cited by 173 · see citing works
Self-citationDai, M., Sun, X., & Lu, H. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01662-07 · Cited by 174 · see citing works
Ribosomal Proteins RPL37, RPS15 and RPS20 Regulate the Mdm2-p53-MdmX Network
Daftuar, L., Zhu, Y. Y., Jacq, X., & Prives, C. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068667 · Cited by 173 · see citing works
Targeting Mdm2 and Mdmx in cancer therapy: better living through medicinal chemistry?
Wade, M., & Wahl, G. M. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0423 · Cited by 170 · see citing works
The role of ubiquitin modification in the regulation of p53
Hock, A. K., & Vousden, K. H. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.05.022 · Cited by 168 · see citing works
Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis
Bursać, S., Brdovčak, M. C., Donati, G., & Volarević, S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.08.014 · Cited by 154 · see citing works
Protein degradation and the stress response
Flick, K. M., & Kaiser, P. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.01.019 · Cited by 133 · see citing works
MDM2 and MDMX: Alone and together in regulation of p53.
Shadfan, M., Lopez-Pajares, V., & Yuan, Z.-M. (2012) · PubMed · Cited by 125 · see citing works
Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3
LeBron, C., Chen, L., Gilkes, D. M., & Chen, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601032 · Cited by 122 · see citing works
Self-citationp53 -Dependent and -Independent Nucleolar Stress Responses
Olausson, K. H., Nistér, M., & Lindström, M. S. (2012) · Cells · doi:10.3390/cells1040774 · Cited by 116 · see citing works
Mdm2 and MdmX partner to regulate p53
Wang, X., & Jiang, X. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.02.049 · Cited by 111 · see citing works
Polyadenylation and degradation of incomplete RNA polymerase I transcripts in mammalian cells
Shcherbik, N., Wang, M., Lapik, Y. R., Srivastava, L., & Pestov, D. G. (2010) · EMBO Reports · doi:10.1038/embor.2009.271 · Cited by 109 · see citing works
Identification of ribosomal protein S25 (RPS25)–MDM2–p53 regulatory feedback loop
Zhang, X., Wang, W., Wang, H., Wang, M.-H., Xu, W., & Zhang, R. (2012) · Oncogene · doi:10.1038/onc.2012.289 · Cited by 106 · see citing works
AMP-Activated Protein Kinase Induces p53 by Phosphorylating MDMX and Inhibiting Its Activity
He, G., Zhang, Y.-W., Lee, J., Zeng, S. X., Wang, Y. V., Luo, Z., Dong, X. C., Viollet, B., Wahl, G. M., & Lu, H. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00670-13 · Cited by 105 · see citing works
MdmX is a substrate for the deubiquitinating enzyme USP2a
Allende-Vega, N., Sparks, A., Lane, D. P., & Saville, M. K. (2010) · Oncogene · doi:10.1038/onc.2009.330 · Cited by 100 · see citing works
Ribosomal proteins as unrevealed caretakers for cellular stress and genomic instability
Kim, T. H., Leslie, P. L., & Zhang, Y. (2014) · Oncotarget · doi:10.18632/oncotarget.1784 · Cited by 100 · see citing works
Donati, G., Bertoni, S., Brighenti, E., Vici, M., Treré, D., Volarević, S., Montanaro, L., & Derenzini, M. (2011) · Oncogene · doi:10.1038/onc.2011.48 · Cited by 95 · see citing works
Teng, T., Mercer, C. A., Hexley, P., Thomas, G., & Fumagalli, S. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01174-13 · Cited by 98 · see citing works
Guarding the ‘translation apparatus’: defective ribosome biogenesis and the p53 signaling pathway
Chakraborty, A., Uechi, T., & Kenmochi, N. (2011) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.73 · Cited by 96 · see citing works
Antitumor effect of miR-197 targeting in p53 wild-type lung cancer
Fiori, M. E., Barbini, C., Haas, T. L., Marroncelli, N., Patrizii, M., Biffoni, M., & Maria, R. D. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.6 · Cited by 94 · see citing works
Structure of human MDM2 complexed with RPL11 reveals the molecular basis of p53 activationPreprint
Zheng, J., Lang, Y., Zhang, Q., Cui, D., Sun, H., Jiang, L., Chen, Z., Zhang, R., Gao, Y., Tian, W., et al. (2015) · Genes & Development · doi:10.1101/gad.261792.115 · Cited by 91 · see citing works
The Regulation of the p53-mediated Stress Response by MDM2 and MDM4Preprint
Perry, M. E. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000968 · Cited by 92 · see citing works
Li, H., Zhang, H., Huang, G., Bing, Z., Xu, D., Liu, J., Luo, H., & An, X. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02230-z · Cited by 88 · see citing works
Versatile functions of p53 protein in multicellular organisms
Chumakov, P. M. (2007) · Biochemistry (Moscow) · doi:10.1134/s0006297907130019 · Cited by 84 · see citing works
MDMX (MDM4), a Promising Target for p53 Reactivation Therapy and BeyondPreprint
Marine, J., & Jochemsen, A. G. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026237 · Cited by 81 · see citing works
Regulation of MDMX Expression by Mitogenic Signaling
Gilkes, D. M., Pan, Y., Coppola, D., Yeatman, T., Reuther, G. W., & Chen, J. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01633-07 · Cited by 82 · see citing works
Self-citationSun, X., Wang, Y.-G., Xirodimas, D. P., & Dai, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.098442 · Cited by 79 · see citing works
Mancini, F., Conza, G. D., Pellegrino, M., Rinaldo, C., Prodosmo, A., Giglio, S., D’Agnano, I., Florenzano, F., Felicioni, L., Buttitta, F., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.154 · Cited by 81 · see citing works
Regulation of the HDM2-p53 pathway by ribosomal protein L6 in response to ribosomal stress
Bai, D., Zhang, J., Xiao, W., & Zheng, X. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt971 · Cited by 79 · see citing works
Scission of the p53-MDM2 Loop by Ribosomal Proteins
Zhou, X. Y., Liao, J.-M., Liao, W.-J., & Lu, H. (2012) · Genes & Cancer · doi:10.1177/1947601912455200 · Cited by 78 · see citing works
The Evolution of the Ribosomal Protein–MDM2–p53 PathwayPreprint
Deisenroth, C., Franklin, D. A., & Zhang, Y. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026138 · Cited by 71 · see citing works
Nucleolus and Nucleolar Stress: From Cell Fate Decision to Disease Development
Hua, L., Yan, D., Wan, C., & Hu, B. (2022) · Cells · doi:10.3390/cells11193017 · Cited by 71 · see citing works
Inhibition of p53 DNA Binding Function by the MDM2 Protein Acidic Domain
Cross, B. L., Chen, L., Cheng, Q., Li, B., Yuan, Z.-M., & Chen, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.228981 · Cited by 69 · see citing works
Self-citationThe long and the short of it: the MDM4 tail so far
Haupt, S., Mejía-Hernández, J. O., Vijayakumaran, R., Keam, S. P., & Haupt, Y. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz007 · Cited by 69 · see citing works
Feedback Regulation of c-Myc by Ribosomal Protein L11
Dai, M., Sears, R. C., & Lu, H. (2007) · Cell Cycle · doi:10.4161/cc.6.22.4895 · Cited by 67 · see citing works
Cortés-López, M., Chamely, P., Hawkins, A. G., Stanley, R. F., Swett, A. D., Ganesan, S., Mouhieddine, T. H., Dai, X., Kluegel, L., Chen, C. Y., et al. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.07.012 · Cited by 67 · see citing works
Lindström, M. S., Deisenroth, C., & Zhang, Y. (2007) · Cell Cycle · doi:10.4161/cc.6.4.3861 · Cited by 65 · see citing works
p53 inactivation by MDM2 and MDMX negative feedback loops in testicular germ cell tumors
Li, B., Cheng, Q., Li, Z., & Chen, J. (2010) · Cell Cycle · doi:10.4161/cc.9.7.11255 · Cited by 64 · see citing works
Self-citationXiong, X., Zhao, Y., Tang, F., Wei, D., Thomas, D. G., Wang, X., Liu, Y., Zheng, P., & Sun, Y. (2014) · eLife · doi:10.7554/elife.02236 · Cited by 66 · see citing works
Deisenroth, C., & Zhang, Y. (2011) · Genes & Cancer · doi:10.1177/1947601911409737 · Cited by 64 · see citing works
Wang, C., Wang, J., Liu, Z., Ma, X., Wang, X., Jin, H. D., Zhang, X.-P., Fu, D., Hou, L., & Lu, Y. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu015 · Cited by 62 · see citing works
MDM2 recruitment of lysine methyltransferases regulates p53 transcriptional output
Chen, L., Li, Z., Zwolińska, A., Smith, M. A., Cross, B. L., Koomen, J. M., Yuan, Z.-M., Jenuwein, T., Marine, J., Wright, K. L., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.140 · Cited by 61 · see citing works
Self-citationPhillips, A., Teunisse, A., Lam, S., Lodder, K., Darley, M., Emaduddin, M., Wolf, A., Richter, J., de Lange, J., Verlaan-de Vries, M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.129726 · Cited by 55 · see citing works
Deubiquitinating enzyme regulation of the p53 pathway: A lesson from Otub1
Sun, X. (2014) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v5.i2.75 · Cited by 55 · see citing works
Tsvetkov, P., Reuven, N. B., Prives, C. L., & Shaul, Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.040493 · Cited by 54 · see citing works
Nucleolar control of p53: a cellular Achilles’ heel and a target for cancer therapy
Vlatković, N., Boyd, M. T., & Rubbi, C. P. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1361-x · Cited by 53 · see citing works
Secondary interaction between MDMX and p53 core domain inhibits p53 DNA binding.
Wei, X., Wu, S., Song, T., Chen, L., Gao, M., Borcherds, W., Daughdrill, G. W., & Chen, J. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603838113 · Cited by 50 · see citing works
Self-citationA Critical Role for Noncoding 5S rRNA in Regulating Mdmx Stability
Li, M., & Gu, W. J. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.020 · Cited by 50 · see citing works
Lo, D., & Lu, H. (2010) · Cell Cycle · doi:10.4161/cc.9.16.12605 · Cited by 50 · see citing works
Autoinhibition of MDMX by intramolecular p53 mimicry
Chen, L., Borcherds, W. M., Wu, S., Becker, A., Schönbrunn, E., Daughdrill, G. W., & Chen, J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1420833112 · Cited by 49 · see citing works
Self-citationCasein Kinase 1α Regulates an MDMX Intramolecular Interaction To Stimulate p53 Binding
Wu, S., Chen, L., Becker, A., Schönbrunn, E., & Chen, J. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00851-12 · Cited by 48 · see citing works
Self-citationSpinnler, C., Hedström, E., Li, H., de Lange, J., Nikulenkov, F., Teunisse, A. F. A. S., Vries, M. V., Grinkevich, V. V., Jochemsen, A. G., & Selivanova, G. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.45 · Cited by 42 · see citing works
Clinical approach to marrow failure
Shimamura, A. (2009) · Hematology · doi:10.1182/asheducation-2009.1.329 · Cited by 41 · see citing works
Anatomy of Mdm2 and Mdm4 in evolution
Tan, B. X., Liew, H. P., Chua, J. S., Ghadessy, F. J., Tan, Y. S., Lane, D. P., & Coffill, C. R. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx002 · Cited by 40 · see citing works
The Pharmacodynamics of the p53-Mdm2 Targeting Drug Nutlin: The Role of Gene-Switching Noise
Puszyński, K., Gandolfi, A., & d’Onofrio, A. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003991 · Cited by 39 · see citing works
Full-length hdmX transcripts decrease following genotoxic stress
Markey, M., & Berberich, S. J. (2008) · Oncogene · doi:10.1038/onc.2008.266 · Cited by 38 · see citing works
Functions of MDMX in the Modulation of the p53‐Response
Lenos, K., & Jochemsen, A. G. (2011) · BioMed Research International · doi:10.1155/2011/876173 · Cited by 38 · see citing works
Specific domains of nucleolin interact with Hdm2 and antagonize Hdm2‐mediated p53 ubiquitination
Bhatt, P., d’Avout, C., Kane, N. S., Borowiec, J. A., & Saxena, A. D. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08430.x · Cited by 37 · see citing works
Characterization of an HIV-Targeted Transcriptional Gene-Silencing RNA in Primary Cells
Turner, A. W., Ackley, A., Matrone, M. A., & Morris, K. V. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.165 · Cited by 37 · see citing works
CDK9 activity is critical for maintaining MDM4 overexpression in tumor cells
Štětková, M., Growková, K., Fojtík, P., Valčíková, B., Palušová, V., Verlande, A., Jorda, R., Kryštof, V., Hejret, V., Alexiou, P., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02971-3 · Cited by 34 · see citing works
The roles of MDM2 and MDMX phosphorylation in stress signaling to p53
Chen, J. (2012) · Genes & Cancer · doi:10.1177/1947601912454733 · Cited by 33 · see citing works
Self-citationZhang, Q., Xiao, H., Chai, S. C., Hoang, Q. Q., & Lu, H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277012 · Cited by 34 · see citing works
Abnormal MDMX degradation in tumor cells due to ARF deficiency
Li, X., Gilkes, D., Li, B., Cheng, Q., Pernazza, D., Lawrence, H., Lawrence, N., & Chen, J. (2012) · Oncogene · doi:10.1038/onc.2011.534 · Cited by 32 · see citing works
Self-citationBadrock, A. P., Uggenti, C., Wacheul, L., Crilly, S., Jenkinson, E. M., Rice, G., Kasher, P. R., Lafontaine, D. L. J., Crow, Y. J., & O’Keefe, R. T. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.04.003 · Cited by 31 · see citing works
Lorenz, L. D., Cardona, J. R., & Lambert, P. F. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003717 · Cited by 28 · see citing works
Regulatory Roles of Rpl22 in Hematopoiesis: An Old Dog with New Tricks
Fahl, S. P., Wang, M., Zhang, Y., Duc, A. E., & Wiest, D. L. (2015) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v35.i5.30 · Cited by 26 · see citing works
Ubiquitin and Ubiquitin-Like Proteins in the Nucleolus: Multitasking Tools for a Ribosome Factory
Shcherbik, N., & Pestov, D. G. (2010) · Genes & Cancer · doi:10.1177/1947601910381382 · Cited by 26 · see citing works
Juban, G., Giraud, G., Guyot, B., Belin, S., Diaz, J., Starck, J., Guillouf, C., Moreau-Gachelin, F., & Morlé, F. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01435-08 · Cited by 26 · see citing works
Saei, A. A., Sabatier, P., Güler, Ü., Chernobrovkin, A. L., Pirmoradian, M., & Zubarev, R. A. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.000610 · Cited by 26 · see citing works
Castro, M. E., Martínez-Leal, J. F., LLeonart, M. E., y Cajal, S. R., & Carnero, A. (2008) · Carcinogenesis · doi:10.1093/carcin/bgm302 · Cited by 25 · see citing works
14-3-3γ Inhibition of MDMX-mediated p21 Turnover Independent of p53
Lee, J., & Lu, H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.190470 · Cited by 22 · see citing works
The tumor suppressor p53 connects ribosome biogenesis to cell cycle control: a double-edged sword
Hölzel, M., Burger, K., Mühl, B., Orban, M., Kellner, M., & Eick, D. (2010) · Oncotarget · doi:10.18632/oncotarget.107 · Cited by 24 · see citing works
Li, H., Zhang, H., Huang, G., Dou, Z., Xie, Y., Si, J., & Di, C. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.110831 · Cited by 24 · see citing works
Markey, M. P. (2010) · Frontiers in bioscience · doi:10.2741/3780 · Cited by 24 · see citing works
Zhang, M., Zhang, J., Yan, W., & Chen, X. (2016) · Oncotarget · doi:10.18632/oncotarget.13126 · Cited by 23 · see citing works
Suppression of p53 Activity through the Cooperative Action of Ski and Histone Deacetylase SIRT1
Inoue, Y., Iemura, S., Natsume, T., Miyazawa, K., & Imamura, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.177683 · Cited by 23 · see citing works
HdmX overexpression inhibits oncogene induced cellular senescence
Miller, K. R., Kelley, K. D., Tuttle, R., & Berberich, S. J. (2010) · Cell Cycle · doi:10.4161/cc.9.16.12779 · Cited by 21 · see citing works
MDMX acidic domain inhibits p53 DNA binding in vivo and regulates tumorigenesis
Huang, Q., Chen, L., Yang, L., Xie, X., Gan, L., Cleveland, J. L., & Chen, J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1719090115 · Cited by 21 · see citing works
Self-citationNovel anti-flavivirus drugs targeting the nucleolar distribution of core protein
Tokunaga, M., Miyamoto, Y., Suzuki, T., Otani, M., Inuki, S., Esaki, T., Nagao, C., Mizuguchi, K., Ohno, H., Yoneda, Y., et al. (2019) · Virology · doi:10.1016/j.virol.2019.11.015 · Cited by 21 · see citing works
Fuchs, O. (2012) · Leukemia Research and Treatment · doi:10.1155/2012/179402 · Cited by 20 · see citing works
Tissue specificity and spatio-temporal dynamics of the p53 transcriptional program
Pant, V., Sun, C., & Lozano, G. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01123-2 · Cited by 21 · see citing works
MDM4 alternative splicing and implication in MDM4 targeted cancer therapies.
Wu, J., Lu, G., & Wang, X. (2021) · PubMed Central · Cited by 19 · see citing works
Lin, Y., Xie, G., Ji, X., Su, D., Liu, J., Jiang, F., & Xu, Y. (2015) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2015.11.001 · Cited by 17 · see citing works
MDM2 oligomers: antagonizers of the guardian of the genome
Leslie, P. L., & Zhang, Y. (2016) · Oncogene · doi:10.1038/onc.2016.88 · Cited by 17 · see citing works
Downregulation of Mdm2 and Mdm4 enhances viral gene expression during adenovirus infection
Yang, H., Zheng, Z., Zhao, L., Li, Q., & Liao, D. (2012) · Cell Cycle · doi:10.4161/cc.11.3.19052 · Cited by 17 · see citing works
- Authors
- Gilkes, D. M., Chen, L., & Chen, J.
- Affiliations
- Moffitt Cancer Center (US)
- Corresponding author
- Chen, Jiandong
- Venue
- The EMBO Journal
- Published
- 2006-11-16
- Volume
- 25
- Issue
- 23
- Pages
- 5614-5625
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC1679771
- OpenAlex
- W2119121049
- Cited by
- 142
- References
- 57
- Citations by year
- 2025: 3 · 2024: 3 · 2023: 3 · 2022: 8 · 2021: 3 · 2020: 4 · 2019: 6 · 2018: 4 · 2017: 2 · 2016: 9 · 2015: 4 · 2014: 9 · 2013: 12 · 2012: 14
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- The EMBO Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Cancer Society
- University of South Florida
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- MDMX, p53, ribosomal stress, rRNA biogenesis, MDM2, p53 degradation, ribosomal proteins, nucleolus, actinomycin D, 5-fluorouracil, chemoresistance, tumor xenografts, growth arrest
- MeSH terms
- Animals, Antineoplastic Agents, Dactinomycin, DNA Damage, Female, Fluorouracil, Humans, Mice, Nude, Neoplasms, Nuclear Proteins, Proto-Oncogene Proteins, Ribosomal Proteins, Ribosomes, RNA, Ribosomal, Tumor Suppressor Protein p53, Cell Cycle Proteins, Drug Resistance, Neoplasm, Xenograft Model Antitumor Assays, Cell Line, Tumor, Cell Proliferation, Mice, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review